Entry |
|
Name |
Chlordiazepoxide hydrochloride (JAN/USP); Librium (TN) |
Product |
|
Generic |
CHLORDIAZEPOXIDE HYDROCHLORIDE (Aphena Pharma Solutions - Tennessee), CHLORDIAZEPOXIDE HYDROCHLORIDE (Chartwell RX), CHLORDIAZEPOXIDE HYDROCHLORIDE (Clinical Solutions Wholesale), CHLORDIAZEPOXIDE HYDROCHLORIDE (Clinical Solutions Wholesale), CHLORDIAZEPOXIDE HYDROCHLORIDE (Epic Pharma LLC), CHLORDIAZEPOXIDE HYDROCHLORIDE (Epic Pharma), CHLORDIAZEPOXIDE HYDROCHLORIDE (Mylan Institutional), CHLORDIAZEPOXIDE HYDROCHLORIDE (NuCare Pharmaceuticals), CHLORDIAZEPOXIDE HYDROCHLORIDE (NuCare Pharmaceuticals), CHLORDIAZEPOXIDE HYDROCHLORIDE (PD-Rx Pharmaceuticals), CHLORDIAZEPOXIDE HYDROCHLORIDE (REMEDYREPACK), CHLORDIAZEPOXIDE HYDROCHLORIDE (REMEDYREPACK), CHLORDIAZEPOXIDE HYDROCHLORIDE (REMEDYREPACK), CHLORDIAZEPOXIDE HYDROCHLORIDE (RPK Pharmaceuticals), CHLORDIAZEPOXIDE HYDROCHLORIDE (Redpharm Drug), CHLORDIAZEPOXIDE HYDROCHLORIDE (Teva Pharmaceuticals USA) |
Formula |
C16H14ClN3O. HCl
|
Exact mass |
335.0592
|
Mol weight |
336.2158
|
Structure |
|
Simcomp |
|
Class |
Neuropsychiatric agent
DG01567 GABA-A receptor agonist
DG01914 Anxiolytics, benzodiazepine derivatives
|
Remark |
Product (DG00908): | D00267<JP> D00693<US> |
Product (mixture): | D10247<US> |
|
Efficacy |
Sedative-hypnotic |
Disease |
|
Comment |
Benzodiazepine derivative
|
Target |
|
Pathway |
hsa04080 | Neuroactive ligand-receptor interaction |
|
Interaction |
|
Structure map |
map07230 | GABA-A receptor agonists/antagonists |
|
Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
N NERVOUS SYSTEM
N05 PSYCHOLEPTICS
N05B ANXIOLYTICS
N05BA Benzodiazepine derivatives
N05BA02 Chlordiazepoxide
D00693 Chlordiazepoxide hydrochloride (JAN/USP) <US>
USP drug classification [BR:br08302]
Anxiolytics
Benzodiazepines
Chlordiazepoxide
D00693 Chlordiazepoxide hydrochloride (JAN/USP)
Drug groups [BR:br08330]
Neuropsychiatric agent
DG01567 GABA-A receptor agonist
DG00908 Chlordiazepoxide
D00693 Chlordiazepoxide hydrochloride
DG01914 Anxiolytics, benzodiazepine derivatives
DG00908 Chlordiazepoxide
D00693 Chlordiazepoxide hydrochloride
Target-based classification of drugs [BR:br08310]
Ion channels
Ligand-gated ion channels
GABA (ionotropic)
GABR
D00693 Chlordiazepoxide hydrochloride (JAN/USP) <US>
Drug groups [BR:br08330]
Neuropsychiatric agent
DG01567 GABA-A receptor agonist
DG00908 Chlordiazepoxide
DG01914 Anxiolytics, benzodiazepine derivatives
DG00908 Chlordiazepoxide
|
Other DBs |
|
KCF data |
ATOM 22
1 C2y C 27.1723 -15.8483
2 C8y C 26.3292 -14.7374
3 C8y C 26.6648 -13.3790
4 N2x N 27.9273 -12.8002
5 N2y N 28.5798 -15.8036 #+
6 C2y C 29.1824 -13.4232
7 C1x C 29.4693 -14.7936
8 C8x C 25.6565 -12.4094
9 C8x C 24.3129 -12.7980
10 C8y C 23.9773 -14.1564
11 C8x C 24.9856 -15.1257
12 C1a C 31.5608 -12.9254
13 N1b N 30.2278 -12.4877
14 X Cl 22.6109 -14.5513
15 C8y C 26.5371 -17.0995
16 C8x C 25.1338 -17.0995
17 O3a O 29.1538 -17.1181 #-
18 C8x C 24.4330 -18.3135
19 C8x C 25.1338 -19.5273
20 C8x C 26.5371 -19.5273
21 C8x C 27.2379 -18.3135
22 X Cl 31.4300 -19.0400
BOND 23
1 3 4 1
2 1 5 2
3 4 6 2
4 2 3 1
5 5 7 1
6 1 2 1
7 6 7 1
8 3 8 2
9 8 9 1
10 9 10 2
11 10 11 1
12 2 11 2
13 12 13 1
14 6 13 1
15 10 14 1
16 1 15 1
17 15 16 1
18 5 17 1
19 16 18 2
20 18 19 1
21 19 20 2
22 20 21 1
23 15 21 2
|